Using intravenous ketamine for patients in a suicidal crisis: when and how they are referred
Updated
Abstract
Intravenous (IV) ketamine may rapidly reduce suicidal ideation and psychological distress within hours.
- IV ketamine is a therapeutic option specifically for treatment-resistant depression and acute suicidal crisis.
- Its effects are distinct from conventional antidepressants, which typically take longer to act.
- Hospital-based care is necessary for its administration, involving medical monitoring and psychiatric assessment.
- The article outlines indications and referral criteria for primary care physicians regarding IV ketamine use.
Simplified